| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 4.62 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 8.08 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 16 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 19.2 | Peak area | Post remission |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 19.9 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 22.6 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 24.8 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 25.3 | Peak area | Post remission |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 30.4 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 33.2 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 35.2 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 39.1 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 39.2 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 40.9 | Peak area | Post remission |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 45.6 | Peak area | Post remission |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 58.6 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 77.3 | Peak area | Post remission |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 79.8 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 83.3 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 86.2 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 111 | Peak area | Post remission |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 122 | Peak area | Post remission |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 125 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 174 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 397 | Peak area | Diagnosis -No treatment |
| ESI/Orbitrap Negative ion mode | Docosahexaenoic Acid (22:6) | 452 | Peak area | Diagnosis -No treatment |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|